参松养心胶囊联合美托洛尔缓释片治疗老年冠心病心律失常疗效分析

Curative effect analysis of shensong yangxin capsule joint metoprolol sustained-release tablets in the treatment of senile coronary heart disease with arrhythmia

目的:探讨参松养心胶囊联合美托洛尔缓释片治疗老年冠心病心律失常的疗效。方法:将冠心病心律失常老年患者100例随机分为两组。对照组采用琥珀酸美托洛尔缓释片治疗,治疗组在琥珀酸美托洛尔缓释片治疗基础上服用参松养心胶囊,比较两组的疗效。结果:治疗组总有效率100%,明显优于对照组总有效率的90%(P<0.05)。结论:参松养心胶囊联合琥珀美托洛尔缓释片治疗冠心病合并心律失常老年患者疗效显著。

Objective:To explore the curative effect of shensong yangxin capsule joint metoprolol sustained-release tablets in the treatment of senile coronary heart disease with arrhythmia.Methods:100 cases of elderly patients with coronary heart disease with arrhythmia were randomly divided into two groups.The control group were given metoprolol succinate sustained-release tablet,and the treatment group were given shensong yangxin capsule on the basis of metoprolol succinate sustained-release tablet.The curative effect of the two groups were compared.Results:The total effective rate of the treatment group was 100% ,which was obviously better than 90% of the control group(P<0.05).Conclusion:Shensong yangxin capsule joint metoprolol succinate sustained-release tablet in the treatment of senile coronary heart disease with arrhythmia had significant curative effect.